Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;38(3):561-567.
doi: 10.1111/pde.14551. Epub 2021 Mar 4.

Primary hyperhidrosis in children: A review of therapeutics

Courtney Remington  1 , Jennifer Ruth  2   3 , Adelaide A Hebert  4
Affiliations
Review

Primary hyperhidrosis in children: A review of therapeutics

Courtney Remington et al. Pediatr Dermatol. 2021 May.

Abstract

Primary hyperhidrosis, an idiopathic disease that commonly affects the palms, soles, axillae, or craniofacial region, is characterized by perspiration in excess of what is required for physiologic cooling. This disease begins in childhood or adolescence and negatively impacts emotional, physical, and psychologic well-being. This review explores current therapeutic options for primary hyperhidrosis in the pediatric population, including topical therapies, oral therapies, non-surgical and procedural interventions, and adjunctive therapies. In addition, this review identifies new and emerging treatments and highlights the need for further research and therapeutic options for this impactful disease.

Keywords: aluminum chloride; glycopyrrolate; glycopyrronium tosylate; hyperhidrosis; iontophoresis; oxybutynin.

PubMed Disclaimer

References

REFERENCES

    1. Kurta AO, Glaser DA, et al. Hyperhidrosis and anhidrosis. In: Kang S, Amagai M, Bruckner AL, eds. Fitzpatrick’s Dermatology, 9e. New York, NY: McGraw-Hill Education; 2019:1459-1468.
    1. Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016;308(10):743-749. https://doi.org/10.1007/s00403-016-1697-9
    1. Bahar R, Zhou P, Liu Y, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol. 2016;75(6):1126-1133. https://doi.org/10.1016/j.jaad.2016.07.001
    1. Hölzle E, Braun-Falco O. Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution. Br J Dermatol. 1984;110(4):399-403. https://doi.org/10.1111/j.1365-2133.1984.tb04653.x
    1. Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review. J Am Acad Dermatol. 2019;81(3):669-680. https://doi.org/10.1016/j.jaad.2018.11.066